放射性核素标记铃蟾肽在前列腺癌诊治中的研究进展  

Progress of radiolabeUed bombesin in diagnosis and treatment of prostate cancer

作　　者：邢岩[1] 赵晋华[1] 

机构地区：[1]上海交通大学第一人民医院核医学科,200080

出　　处：《国际放射医学核医学杂志》2010年第3期158-160,共3页International Journal of Radiation Medicine and Nuclear Medicine

摘　　要：前列腺癌等多种肿瘤细胞表面能过度表达铃蟾肽受体，因此，铃蟾肽及其受体可以作为靶点进行放射性核素受体显像及靶向治疗肿瘤，并成为近年来诊治前列腺癌的研究热点。该文综述了放射性核素标记铃蟾肽在前列腺癌显像及治疗方面的研究进展。Studies show that high expression of bombesin exist in the face of many kind of tumors such as prostate cancer, so bombesin and its receptor can be used as target in radionuclide receptor imaging and targeted therapy of tumor, and become the focus of prostate cancer research. This article reviews the progress of radiolabelled bombesin in prostate cancer imaging and therapy.

关 键 词：雨蛙肽 前列腺肿瘤 放射性核素显像 近距离放射疗法 

分 类 号：R737[医药卫生—肿瘤]